Wogonin induces beclin-1/PI3K and reactive oxygenspecies-mediated autophagy in human pancreatic cancer cells

Oncology Letters

Volumn 12, Issue 6, 2016, Pages 5059-5067

  Li, Shao Jun ^a   Sun, Shi Jie ^a   Gao, Jie ^a   Sun, Fu Bo ^a  

^a YANTAI YUHUANGDING HOSPITAL   (China)

Author keywords

Autophagy; Human pancreatic cancer cells; Reactive oxygen species; Wogonin

Indexed keywords

BECLIN 1; GLUTATHIONE; WOGONIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL VIABILITY ASSAY; FLOW CYTOMETRY; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; PANCREAS CANCER; PROTEIN DEGRADATION; PROTEIN EXPRESSION; TRANSMISSION ELECTRON MICROSCOPY; WESTERN BLOTTING;

EID: 84995801527     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2016.5367     Document Type: Article

References (36)

1. Siegel R, Naishadham D and Jemal A: Cancer statistics 2013. CA Cancer J Clin 63: 11-30, 2013.
2. Diener MK, Combs SE and Büchler MW: Chemoradiotherapy for locally advanced pancreatic cancer. Lancet Oncol 14: 269-270, 2013.
3. Akimoto M, Iizuka M, Kanematsu R, Yoshida M and Takenaga K: Anticancer effect of ginger extract against pancreatic cancer cells mainly through reactive oxygen species-mediated autotic cell death. PLoS One 10: e0126605, 2015.
4. Lewis CS, Voelkel-Johnson C and Smith CD: Suppression of c-Myc and RRM2 expression in pancreatic cancer cells by the sphingosine kinase-2 inhibitor ABC294640. Oncotarget 2016. [Epub ahead of print]
5. Mandhare A, Biradar S and Gurule A: Azaepothilone B and its derivatives: A patent review. Expert Opin Ther Pat 26: 891-905, 2016.
6. Pourmorteza M, Rahman ZU and Young M: Evofosfamide, a new horizon in the treatment of pancreatic cancer. Anticancer Drugs 27: 723-725, 2016.
7. Polier G, Ding J, Konkimalla BV, Eick D, Ribeiro N, Köhler R, Giaisi M, Efferth T, Desaubry L, Krammer PH and Li-Weber M: Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Cell Death Dis 2: e182, 2011.
8. Polier G, Giaisi M, Köhler R, Müller WW, Lutz C, Buss EC, Krammer PH and Li-Weber M: Targeting CDK9 by wogonin and related natural flavones potentiates the anti-cancer efficacy of the Bcl-2 family inhibitor ABT-263. Int J Cancer 136: 688-698, 2015.
9. Baumann S, Fas SC, Giaisi M, Müller WW, Merling A, Gülow K, Edler L, Krammer PH and Li-Weber M: Wogonin preferentially kills malignant lymphocytes and suppresses T-cell tumor growth by inducing PLCgamma1-and Ca2+-dependent apoptosis. Blood 111: 2354-2363, 2008.
10. Yang H, Hui H, Wang Q, Li H, Zhao K, Zhou Y, Zhu Y, Wang X, You Q, Guo Q and Lu N: Wogonin induces cell cycle arrest and erythroid differentiation in imatinib-resistant K562 cells and primary CML cells. Oncotarget 5: 8188-8201, 2014.
11. Takahashi H, Chen MC, Pham H, Angst E, King JC, Park J, Brovman EY, Ishiguro H, Harris DM, Reber HA, et al: Baicalein, a component of Scutellaria baicalensis, induces apoptosis by Mcl-1 down-regulation in human pancreatic cancer cells. Biochim Biophys Acta 1813: 1465-1474, 2011.
12. Kallifatidis G, Rausch V, Baumann B, Apel A, Beckermann BM, Groth A, Mattern J, Li Z, Kolb A, Moldenhauer G, et al: Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling. Gut 58: 949-963, 2009.
13. Chen N and Karantza V: Autophagy as a therapeutic target in cancer. Cancer Biol Ther 11: 157-168, 2011.
14. Chow SE, Chen YW, Liang CA, Huang YK and Wang JS: Wogonin induces cross-regulation between autophagy and apoptosis via a variety of Akt pathway in human nasopharyngeal carcinoma cells. J Cell Biochem 113: 3476-3485, 2012.
15. Zhu Y and Wang J: Wogonin increases β-amyloid clearance and inhibits tau phosphorylation via inhibition of mammalian target of rapamycin: Potential drug to treat Alzheimer's disease. Neurol Sci 36: 1181-1188, 2015.
16. Klionsky DJ, Abdelmohsen K, Abe A, Abedin MJ, Abeliovich H, Acevedo Arozena A, Adachi H, Adams CM, Adams PD, Adeli K, et al: Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition). Autophagy 12: 1-222, 2016.
17. Steinbrenner J, Eldridge M, Tomé DF and Beynon JL: A simple and fast protocol for the protein complex immunoprecipitation (Co-IP) of effector: Host protein complexes. Methods Mol Biol 1127: 195-211, 2014.
18. Mikhaylova O, Stratton Y, Hall D, Kellner E, Ehmer B, Drew AF, Gallo CA, Plas DR, Biesiada J, Meller J and Czyzyk-Krzeska MF: VHL-regulated MiR-204 suppresses tumor growth through inhibition of LC3B-mediated autophagy in renal clear cell carcinoma. Cancer Cell 21: 532-546, 2012.
19. Russell RC, Tian Y, Yuan H, Park HW, Chang YY, Kim J, Kim H, Neufeld TP, Dillin A and Guan KL: ULK1 induces autophagy by phosphorylating Beclin-1 and activating VPS34 lipid kinase. Nat Cell Biol 15: 741-750, 2013.
20. Lee DH, Lee TH, Jung CH and Kim YH: Wogonin induces apoptosis by activating the AMPK and p53 signaling pathways in human glioblastoma cells. Cell Signal 24: 2216-25, 2012.
21. Thomas HE, Mercer CA, Carnevalli LS, Park J, Andersen JB, Conner EA, Tanaka K, Matsutani T, Iwanami A, Aronow BJ, et al: mTOR inhibitors synergize on regression, reversal of gene expression, and autophagy in hepatocellular carcinoma. Sci Transl Med 4: 139ra84, 2012.
22. Xiao W, Wu K, Yin M, Han S, Ding Y, Qiao A, Lu G, Deng B, Bo P and Gong W: Wogonin Inhibits Tumor-derived Regulatory Molecules by Suppressing STAT3 Signaling to Promote Tumor Immunity. J Immunother 38: 167-84, 2015.
23. Hu C, Xu M, Qin R, Chen W and Xu X: Wogonin induces apoptosis and endoplasmic reticulum stress in HL-60 leukemia cells through inhibition of the PI3K-AKT signaling pathway. Oncol Rep 33: 3146-3154, 2015.
24. Zhao L, Miao HC, Li WJ, Sun Y, Huang SL, Li ZY and Guo QL: LW-213 induces G2/M cell cycle arrest through AKT/GSK3β/β-catenin signaling pathway in human breast cancer cells. Mol Carcinog 55: 778-792, 2015.
25. Wang W, Xia T and Yu X: Wogonin suppresses inflammatory response and maintains intestinal barrier function via TLR4-MyD88-TAK1-mediated NF-κB pathway in vitro. Inflamm Res 64: 423-431, 2015.
26. Lee JY and Park W: Anti-inflammatory effect of wogonin on RAW 264.7 mouse macrophages induced with polyinosinic-polycytidylic acid. Molecules 20: 6888-6900, 2015.
27. Lucas CD, Dorward DA, Sharma S, Rennie J, Felton JM, Alessandri AL, Duffin R, Schwarze J, Haslett C and Rossi AG: Wogonin induces eosinophil apoptosis and attenuates allergic airway inflammation. Am J Respir Crit Care Med 191: 626-636, 2015.
28. Prieto-Domínguez N, Ordóñez R, Fernández A, García-Palomo A, Muntané J, González-Gallego J and Mauriz JL: Modulation of autophagy by sorafenib: Effects on Treatment Response. Front Pharmacol 7: 151, 2016.
29. Kleger A, Perkhofer L and Seufferlein T: Smarter drugs emerging in pancreatic cancer therapy. Ann Oncol 25: 1260-1270, 2014.
30. Xi G, Hu X, Wu B, Jiang H, Young CY, Pang Y and Yuan H: Autophagy inhibition promotes paclitaxel-induced apoptosis in cancer cells. Cancer Lett 307: 141-148, 2011.
31. Maiuri MC, Tasdemir E, Criollo A, Morselli E, Vicencio JM, Carnuccio R and Kroemer G: Control of autophagy by oncogenes and tumor suppressor genes. Cell Death Differ 16: 87-93, 2009.
32. Scherz-Shouval R and Elazar Z: Regulation of autophagy by ROS: Physiology and pathology. Trends Biochem Sci 36: 30-38, 2011.
33. Zhang J, Kim J, Alexander A, Cai S, Tripathi DN, Dere R, Tee AR, Tait-Mulder J, Di Nardo A, Han JM, et al: A tuberous sclerosis complex signalling node at the peroxisome regulates mTORC1 and autophagyin response to ROS. Nat Cell Biol 15: 1186-1196, 2013.
34. Kim SJ, Jung HJ and Lim CJ: Reactive oxygen species-dependent down-regulation of tumor suppressor genes PTEN, USP28, DRAM, TIGAR, and CYLD under oxidative stress. Biochem Genet 51: 901-915, 2013.
35. Chen C, Liu Y and Zheng D: An agonistic monoclonal antibody against DR5 induces ROS production, sustained JNK activation and Endo G release in Jurkat leukemia cells. Cell Res 19: 984-995, 2009.
36. Bonapace L, Bornhauser BC, Schmitz M, Cario G, Ziegler U, Niggli FK, Schäfer BW, Schrappe M, Stanulla M and Bourquin JP: Induction of autophagy-dependent necroptosis is required for childhood acute lymphoblastic leukemia cells to overcome glucocorticoid resistance. J Clin Invest 120: 1310-1323, 2010.